Ohcanbohtosat - E. P. PANCHENKO

Choice of anticoagulant in patients with atrial fibrillation that occurred in the conditions of COVID-19 (clinical case) Dahkki E. P. Panchenko

Connect to this object online.

Apixaban role in the treatment of venous thromboembolic complications in patients with active cancer Dahkki E. P. Panchenko

Connect to this object online.

Is there still room for warfarin after the appearance of direct oral anticoagulants? Dahkki E. P. Panchenko

Connect to this object online.

PATIENT WITH CAD AND MULTIFOCAL ARTERIAL SCLEROTIC DISEASE (CLINICAL DISCUSSION) Dahkki E. P. Panchenko

Connect to this object online.

WHAT COULD HAVE BEEN DONE DIFFERENTLY? A PATIENT WITH ACUTE CORONARY SYNDROME Dahkki E. P. Panchenko

Connect to this object online.

Antithrombotic therapy in patients with atrial fibrillation and percutaneous coronary intervention: what has changed in the guidelines in 2020? Dahkki E. P. Panchenko

Connect to this object online.

HAVE WE SHIFTED OUR PARADIGM OF CLOPIDOGREL AS A MANDATORY DRUG IN TREATMENT OF CARDIOLOGICAL PATIENTS AFTER THE INTRODUCTION OF MORE POWERFUL ANTIAGREGANTS? Dahkki E. P. PANCHENKO

Connect to this object online.

CHOICE OF ANTIPLATELET THERAPY IN VARIOUS PATIENTS WITH ACUTE CORONARY SYNDROMES Dahkki E. P. Panchenko

Connect to this object online.

NEW ORAL ANTICOAGULANTS IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE Dahkki E. P. Panchenko

Connect to this object online.

Modern concepts of the place of acetylsalicylic acid in the treatment of patients with various manifestations of atherothrombosis Dahkki E. P. Panchenko

Connect to this object online.

SELECTING AN OPTIMAL LONG-TERM ANTICOAGULANT THERAPY FOR A PATIENT WITH ATRIAL FIBRILLATION AND RECURRENT MINOR HEMORRHAGE. CLINICAL FOLLOW-UP Dahkki E. S. Kropacheva, E. P. Panchenko

Connect to this object online.

The place of dabigatran in the treatment of patients with atrial fibrillation in the light of modern recommendations Dahkki E. S. Kropacheva, E. P. Panchenko

Connect to this object online.

NICHE OF PRASUGREL AMONG OTHER PLATELET P2Y12-RECEPTOR INHIBITORS Dahkki P. S. LAGUTA, E. P. PANCHENKO

Connect to this object online.

Aspects of anticoagulant therapy in patients with atrial fibrillation in the light of updated guidelines of the European society of cardiology 2020: the position of dabigatran Dahkki E. S. Kropacheva, E. P. Panchenko

Connect to this object online.

DABIGATRAN ETEXILATE FOR THE TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS Dahkki N. M. Vorobieva, E. P. Panchenko

Connect to this object online.

ANTICOAGULANTS IN THERAPY OF PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION: WHICH DRUG TO BE CHOSEN? Dahkki A. L. Komarov, E. P. Panchenko

Connect to this object online.

APIXABAN IN THE TREATMENT OF ATRIAL FIBRILLATION: RANDOMIZED TRIALS AND EVERYDAY CLINICAL PRACTICE Dahkki O. O. Shakhmatova, E. P. Panchenko

Connect to this object online.

THROMBOSES IN ONCOLOGY. PART 1 Dahkki Y. A. Fedotkina, E. P. Panchenko

Connect to this object online.

THROMBOSIS IN CANCER. PART 2 Dahkki Yu. A. FEDOTKINA, E. P. PANCHENKO

Connect to this object online.

PROPHYLAXIS OF VENOUS THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ACTIVE ONCOLOGICAL DISEASE, RECEIVING MEDICAL ANTI-CANCER CHEMOTHERAPY IN OUTPATIENT CONDITIONS. ROLE OF APIXABA... Dahkki Yu. A. Fedotkina, E. P. Panchenko

Connect to this object online.